Table 1.
Overall Participation and Patient and Disease Characteristics
| All Patients | Adolescents (≥13 y) | Children (8–12 y) | Children (5–7 y) | |
|---|---|---|---|---|
| No. of eligible patients | 71 | 42 | 23 | 6 |
|
| ||||
| No. (%) of participants* | 66 (93%) | 39 (93%) | 21 (91%) | 6 (100%) |
|
| ||||
| Participation^ rate by time point | ||||
| At diagnosis | 65 (92%) | 39 (93%) | 20 (87%) | 6 (100%) |
| Week 12 | 55 (77%) | 33 (79%) | 16 (70%) | 6 (100%) |
| Week 23 | 55 (77%) | 32 (76%) | 17 (74%) | 6 (100%) |
| After completion of therapy | 54 (76%) | 31 (74%) | 18 (78%) | 5 (83%) |
|
| ||||
| Age at Study Enrollment (years) | ||||
| Median | 13.4 | 15.4 | 10.9 | 5.9 |
| Range | 5.0 – 23.0 | 13.0 – 23.0 | 8.0 – 12.6 | 5.0 – 7.1 |
| Mean (standard deviation) | 13.3 (3.9) | 15.9 (2.4) | 10.7 (1.5) | 6.0 (0.8) |
|
| ||||
| Sex (%) | ||||
| Male | 36 (55) | 21 (54) | 13 (62) | 2 (33) |
| Female | 30 (45) | 18 (46) | 8 (38) | 4 (67) |
|
| ||||
| Race (%) | ||||
| White | 28 (42) | 18 (46) | 10 (48) | 0 (0) |
| Black | 11 (17) | 6 (15) | 3 (14) | 2 (33) |
| Hispanic | 27 (41) | 15 (38) | 8 (38) | 4 (67) |
|
| ||||
| Primary Site of Disease (%) | ||||
| Femur | 43 (65) | 23 (59) | 15 (71) | 5 (83) |
| Tibia | 16 (24) | 10 (26) | 5 (24) | 1 (17) |
| Fibula | 2 (3) | 2 (5) | 0 (0) | 0 (0) |
| Humerus | 2 (3) | 2 (5) | 0 (0) | 0 (0) |
| Ulna | 1 (2) | 1 (3) | 0 (0) | 0 (0) |
| Rib | 1 (2) | 1 (3) | 0 (0) | 0 (0) |
| Jaw | 1 (2) | 0 (0) | 1 (5) | 0 (0) |
*
A participant was any patient who completed 1 to 3 HRQOL instruments at 1 or more of the 4 designated time points.
^
Participation was considered as the completion of at least 1 of the 3 HRQOL instruments at the designated time point.